Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

ClinicalTrials.gov ID: NCT01557842

Public ClinicalTrials.gov record NCT01557842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01557842
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Biosense Webster, Inc.
Industry
Enrollment
15 participants

Conditions and interventions

Interventions

  • Drug Treatment Drug
  • Catheter Ablation Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2012
Primary completion
Mar 18, 2014
Completion
Mar 18, 2014
Last update posted
Jun 7, 2017

2012 – 2014

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
University of California, Los Angeles Los Angeles California 90095
California Pacific Medical Center San Francisco California 94115
San Francisco VA Medical Center San Francisco California 94121
University of California, San Francisco San Francisco California 94143
University of Colorado, Denver Aurora Colorado 80045
Florida Hospital Orlando Florida 32803
Loyola University Chicago Maywood Illinois 60153
Central Baptist Hospital Lexington Kentucky 40503
University of Maryland Baltimore Maryland 21201
Johns Hopkins Hospital Baltimore Maryland 21287
Brigham and Women's Hospital Boston Massachusetts 02115
Massachusetts General Hospital Boston Massachusetts 02199
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55902
Mount Sinai School of Medicine New York New York 10029
Columbia University- New York Presbyterian Hospital New York New York 10032
Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University Columbus Ohio 43210
University of Oklahoma Oklahoma City Oklahoma 73104
University of Pennsylvania Philadelphia Pennsylvania 19104
Texas Cardiac Arrhythmia Research Foundation Austin Texas 78705
St. Luke's Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01557842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2017 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01557842 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →